Divi’s Labs Q4 FY25: Growth, Capex & CDMO Push
Divi’s Laboratories Limited, one of India’s foremost pharmaceutical manufacturing and custom synthesis companies, posted a strong performance in Q4 FY25,…
Where Insider Information Meets Opportunity
Divi’s Laboratories Limited, one of India’s foremost pharmaceutical manufacturing and custom synthesis companies, posted a strong performance in Q4 FY25,…
IFCI Limited (NSE: IFCI), a prominent player in India’s financial term lending landscape, has staged an emphatic breakout that aligns…
Cochin Shipyard Breaks Out: Technical Surge Meets Strategic Strength Cochin Shipyard Ltd. (NSE: COCHINSHIP) has made a remarkable technical and…
Belrise Industries IPO 2025: Key Insights, Dates, and Investment Analysis India’s primary market continues to offer a mix of established…
India’s equity markets roared higher this week, driven by a confluence of positive global and domestic cues. The NIFTY50 index…